|
Repositioning of MICE follows group-wide AEI of meetings and events spaces to be the trusted partner for meaningful, high performing meetings and events
SINGAPORE, March 25, 2026 /PRNewswire/ -- Pan Pacific Hotels Group (PPHG) continues its global drive for MICE (Meetings, Incentives, Conferences, and Exhibitions) with the launch of Every Meeting Matters campaign, underscoring its commitment to supporting the evolution of business events in the post-pandemic era.
As global business travel continues its robust recovery, the MICE industry is experiencing unprecedented transformation and growth. The global MICE industry market reached a value of approximately USD 783.70 billion in 2023, according to data by Research and Markets[1]. The market is projected to further grow at a CAGR of 6.7% to reach a value of USD 1,407.45 billion by 2032.
The evolution of meetings is also being shaped by a generational shift in the workforce, which is having a direct impact on the attendee profile at business events. Industry research shows that Millennials and Gen Zs now account for more than 40% of conference participants, with the average age of attendees declining in recent years[2]. This new generation of professionals is driving demand for meetings that are more technology-enabled, wellness-focused and environmentally responsible.
"Business events have evolved significantly in recent years, with organisations seeking experiences that inspire collaboration, creativity and meaningful connections. Anticipating this post pandemic shift, we have strengthened our MICE capabilities across our portfolio, from investing in upgraded event spaces to enhancing service delivery and technology. With the launch of Every Meeting Matters, we reaffirm our commitment to being a trusted partner for impactful meetings and events that deliver value for organisers and delegates alike," said Mr. Choe Peng Sum, Chief Executive Officer of PPHG.
Asia-Pacific: A Region on the Rise
The momentum is equally strong in Asia-Pacific region. Grand View Research estimates the region's MICE market will grow at a CAGR of 10%, reaching approximately USD 355 billion by 2030[3]. The growth is being driven by infrastructure development, regional business integration, and rising demand for corporate travel experiences. The demand is coming from key markets such as Singapore, India, China and Australia.
PPHG has a strong presence in these markets and is uniquely positioned to serve the evolving needs of MICE travellers with its regional network of properties, delivering high-quality venues in prime city-centre locations with easy access, natural-light ballrooms and versatile configurations suited for a range of event formats.
Redefining the MICE Experience: Wellness, Sustainability and Tech
Across the region, corporates and organisers are seeking more than functional meeting rooms. Today's MICE travellers demand experiences that are wellness-oriented, technologically advanced and environmentally responsible.
As hybrid and tech-enabled events become the norm, many PPHG properties are equipped with high-speed connectivity, state-of-the-art audiovisual infrastructure and innovative meeting tools that enable seamless collaboration across in-person and virtual audiences. This includes built-in AV systems, immersive LED walls and on-site technical support to deliver seamless events.
A leading trend is the integration of wellness into meetings and conferences. Delegates now expect nutritious menus, movement breaks and event spaces with natural daylight to promote health and engagement. PPHG is responding by embedding signature wellness experiences across its Pan Pacific, PARKROYAL COLLECTION and PARKROYAL properties.
Across the meetings and events industry, organisers are placing greater emphasis on venues that support sustainability, wellbeing and meaningful delegate experiences. Corporate Request for Proposals (RFP) increasingly prioritise partners that can demonstrate responsible sourcing, reduced environmental impact and wellness-focused event design. In response, PPHG has strengthened its meetings offering across its brands, from sustainability-led experiences at PARKROYAL COLLECTION properties, to locally inspired meetings at PARKROYAL hotels, to elevated service and culinary experiences at Pan Pacific Hotels and Resorts. Initiatives such as reducing single-use items, sourcing ingredients and event materials locally, offering bottled water alternatives, and incorporating wellness breaks and eco-themed activities into event programmes are helping organisers deliver meetings that are both impactful and environmentally responsible.
"Today's meeting planners are looking for more than functional venues. They want spaces that inspire creativity, technology that enables seamless collaboration, and experiences that support wellbeing and sustainability. Our MICE strategy is centred on delivering experiences that combine all these aspects in a seamless manner. Whether it's wellness-inspired breaks, advanced hybrid meeting capabilities or locally sourced culinary experiences, we aim to help organisers create meetings that are both productive and memorable," said Celine Du, Chief Commercial and Marketing Officer at PPHG.
Strategic Investments to Drive Excellence
To support the evolving business events landscape, PPHG has invested in Asset Enhancement Initiatives (AEI) across key Asia-Pacific markets. Notable projects include a full revitalisation of Pan Pacific Perth's 2,500-square-meter convention floor, the city's largest—offering state-of-the-art infrastructure and flexible layouts for immersive experiences.
Additionally, many of the group's hotels are in prime city-centre locations, with excellent transport access, making them an even more attractive as MICE venues.
"We see significant long-term growth in the business events sector, particularly in Asia-Pacific. Our continued investments in meeting and event spaces reflect our confidence in the resilience and future growth of the global MICE industry. By enhancing our venues and evolving our offerings across our brands, we are focused on creating environments where organisations can bring people together, exchange ideas and drive meaningful outcomes," Choe added.
Visit panpacific.com/meetings for more information.
View more hi-res images of some of our MICE spaces here
Sources:
- Research and Markets: MICE Industry Market Report and Forecast 2025-2034
- Freeman Trends Report Q1 2023
- Grand View Research: Asia Pacific MICE Market (2024 -2030)
About Pan Pacific Hotels Group
Pan Pacific Hotels Group is a global hospitality company that owns and manages over 50 hotels, resorts, and serviced suites comprising three brands – "Pan Pacific", PARKROYAL COLLECTION, and PARKROYAL in more than 30 cities across Asia Pacific, North America, Africa and Europe. Headquartered in Singapore, it is a member of Singapore-listed UOL Group Limited.
Pan Pacific Hotels and Resorts delivers sincere and graceful service to every guest with a passion for excellence.
PARKROYAL COLLECTION Hotels & Resorts is driven by our passion for life and sustainability.
PARKROYAL Hotels & Resorts is distinguished by its passion for people and places, immersing every guest into local and authentic cultures.
Visit www.panpacific.com.
Pan Pacific DISCOVERY
Pan Pacific DISCOVERY is a loyalty programme designed to enhance every guest experience. Members can savour the benefits of DISCOVERY Dollars (D$), a user-friendly digital rewards currency, granting exclusive discounts on room rates, dining experiences, and more. With each tier progression, members elevate their status to unlock enhanced privileges and the opportunity to earn and spend D$ on premium hotel amenities and experiences, including Pan Pacific Hotels Group-owned dining outlets worldwide. Pan Pacific DISCOVERY is a member of the Global Hotel Alliance (GHA), the world's largest alliance of independent hotels with 40 brands and over 800 hotels around the world. To become a member, visit panpacific.com.
Repositioning of MICE follows group-wide AEI of meetings and events spaces to be the trusted partner for meaningful, high performing meetings and events
SINGAPORE, March 25, 2026 /PRNewswire/ -- Pan Pacific Hotels Group (PPHG) continues its global drive for MICE (Meetings, Incentives, Conferences, and Exhibitions) with the launch of Every Meeting Matters campaign, underscoring its commitment to supporting the evolution of business events in the post-pandemic era.
As global business travel continues its robust recovery, the MICE industry is experiencing unprecedented transformation and growth. The global MICE industry market reached a value of approximately USD 783.70 billion in 2023, according to data by Research and Markets[1]. The market is projected to further grow at a CAGR of 6.7% to reach a value of USD 1,407.45 billion by 2032.
The evolution of meetings is also being shaped by a generational shift in the workforce, which is having a direct impact on the attendee profile at business events. Industry research shows that Millennials and Gen Zs now account for more than 40% of conference participants, with the average age of attendees declining in recent years[2]. This new generation of professionals is driving demand for meetings that are more technology-enabled, wellness-focused and environmentally responsible.
"Business events have evolved significantly in recent years, with organisations seeking experiences that inspire collaboration, creativity and meaningful connections. Anticipating this post pandemic shift, we have strengthened our MICE capabilities across our portfolio, from investing in upgraded event spaces to enhancing service delivery and technology. With the launch of Every Meeting Matters, we reaffirm our commitment to being a trusted partner for impactful meetings and events that deliver value for organisers and delegates alike," said Mr. Choe Peng Sum, Chief Executive Officer of PPHG.
Asia-Pacific: A Region on the Rise
The momentum is equally strong in Asia-Pacific region. Grand View Research estimates the region's MICE market will grow at a CAGR of 10%, reaching approximately USD 355 billion by 2030[3]. The growth is being driven by infrastructure development, regional business integration, and rising demand for corporate travel experiences. The demand is coming from key markets such as Singapore, India, China and Australia.
PPHG has a strong presence in these markets and is uniquely positioned to serve the evolving needs of MICE travellers with its regional network of properties, delivering high-quality venues in prime city-centre locations with easy access, natural-light ballrooms and versatile configurations suited for a range of event formats.
Redefining the MICE Experience: Wellness, Sustainability and Tech
Across the region, corporates and organisers are seeking more than functional meeting rooms. Today's MICE travellers demand experiences that are wellness-oriented, technologically advanced and environmentally responsible.
As hybrid and tech-enabled events become the norm, many PPHG properties are equipped with high-speed connectivity, state-of-the-art audiovisual infrastructure and innovative meeting tools that enable seamless collaboration across in-person and virtual audiences. This includes built-in AV systems, immersive LED walls and on-site technical support to deliver seamless events.
A leading trend is the integration of wellness into meetings and conferences. Delegates now expect nutritious menus, movement breaks and event spaces with natural daylight to promote health and engagement. PPHG is responding by embedding signature wellness experiences across its Pan Pacific, PARKROYAL COLLECTION and PARKROYAL properties.
Across the meetings and events industry, organisers are placing greater emphasis on venues that support sustainability, wellbeing and meaningful delegate experiences. Corporate Request for Proposals (RFP) increasingly prioritise partners that can demonstrate responsible sourcing, reduced environmental impact and wellness-focused event design. In response, PPHG has strengthened its meetings offering across its brands, from sustainability-led experiences at PARKROYAL COLLECTION properties, to locally inspired meetings at PARKROYAL hotels, to elevated service and culinary experiences at Pan Pacific Hotels and Resorts. Initiatives such as reducing single-use items, sourcing ingredients and event materials locally, offering bottled water alternatives, and incorporating wellness breaks and eco-themed activities into event programmes are helping organisers deliver meetings that are both impactful and environmentally responsible.
"Today's meeting planners are looking for more than functional venues. They want spaces that inspire creativity, technology that enables seamless collaboration, and experiences that support wellbeing and sustainability. Our MICE strategy is centred on delivering experiences that combine all these aspects in a seamless manner. Whether it's wellness-inspired breaks, advanced hybrid meeting capabilities or locally sourced culinary experiences, we aim to help organisers create meetings that are both productive and memorable," said Celine Du, Chief Commercial and Marketing Officer at PPHG.
Strategic Investments to Drive Excellence
To support the evolving business events landscape, PPHG has invested in Asset Enhancement Initiatives (AEI) across key Asia-Pacific markets. Notable projects include a full revitalisation of Pan Pacific Perth's 2,500-square-meter convention floor, the city's largest—offering state-of-the-art infrastructure and flexible layouts for immersive experiences.
Additionally, many of the group's hotels are in prime city-centre locations, with excellent transport access, making them an even more attractive as MICE venues.
"We see significant long-term growth in the business events sector, particularly in Asia-Pacific. Our continued investments in meeting and event spaces reflect our confidence in the resilience and future growth of the global MICE industry. By enhancing our venues and evolving our offerings across our brands, we are focused on creating environments where organisations can bring people together, exchange ideas and drive meaningful outcomes," Choe added.
Visit panpacific.com/meetings for more information.
View more hi-res images of some of our MICE spaces here
Sources:
About Pan Pacific Hotels Group
Pan Pacific Hotels Group is a global hospitality company that owns and manages over 50 hotels, resorts, and serviced suites comprising three brands – "Pan Pacific", PARKROYAL COLLECTION, and PARKROYAL in more than 30 cities across Asia Pacific, North America, Africa and Europe. Headquartered in Singapore, it is a member of Singapore-listed UOL Group Limited.
Pan Pacific Hotels and Resorts delivers sincere and graceful service to every guest with a passion for excellence.
PARKROYAL COLLECTION Hotels & Resorts is driven by our passion for life and sustainability.
PARKROYAL Hotels & Resorts is distinguished by its passion for people and places, immersing every guest into local and authentic cultures.
Visit www.panpacific.com.
Pan Pacific DISCOVERY
Pan Pacific DISCOVERY is a loyalty programme designed to enhance every guest experience. Members can savour the benefits of DISCOVERY Dollars (D$), a user-friendly digital rewards currency, granting exclusive discounts on room rates, dining experiences, and more. With each tier progression, members elevate their status to unlock enhanced privileges and the opportunity to earn and spend D$ on premium hotel amenities and experiences, including Pan Pacific Hotels Group-owned dining outlets worldwide. Pan Pacific DISCOVERY is a member of the Global Hotel Alliance (GHA), the world's largest alliance of independent hotels with 40 brands and over 800 hotels around the world. To become a member, visit panpacific.com.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Pan Pacific Hotels Group Elevates the Business Events Experience with "Every Meeting Matters" Campaign
SHANGHAI, March 25, 2026 /PRNewswire/ -- Hope Medicine Inc., a science-driven, clinical-stage innovative biopharmaceutical company, announced that the first patient has been dosed in the Phase III clinical trial of HMI-115, its first-in-class monoclonal antibody with global rights, for the treatment of endometriosis. The dosing took place at the leading study site in China, Peking Union Medical College Hospital. This Phase III trial is a multicenter, randomized, double-blind, placebo-controlled study designed to confirm the safety and efficacy of HMI-115 in treating moderate-to-severe pain associated with endometriosis, with a treatment period of 24 weeks. HMI-115 is currently the first and only non-hormonal therapy globally to have entered Phase III clinical development.
Previously, HMI-115 was granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA) for the treatment of moderate-to-severe pain associated with endometriosis. Additionally, HMI-115 was granted the Breakthrough Therapy Designation (BTD) by the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA). These recognitions from global regulatory authorities were primarily based on the results from a previously completed global multicenter Phase II clinical trial for HMI-115 in endometriosis, which demonstrated that HMI-115 achieved statistically significant improvement in moderate-to-severe pain associated with endometriosis, with no significant impact on key female hormones and no menopausal side effects. These findings have been published in The Lancet Obstetrics, Gynaecology, & Women's Health. Furthermore, Hope Medicine was nominated as "Best Startup" for the prestigious Prix Galien Award.
Regarding this significant clinical milestone, Professor Xiao Ruiping, Founder of Hope Medicine, stated:
"The initiation of the Phase III clinical trial for HMI-115 in endometriosis, marks a milestone achievement in our clinical development. Peking Union Medical College Hospital, as the leading site, is at the forefront of this Phase III study. Hope Medicine remains unwavering in its original commitment to bringing truly differentiated first-in-class medicines to patients worldwide."
Mr. Chen Xi, Chief Executive Officer of Hope Medicine, also commented:
"The launch of the Phase III trial signifies that the global development of HMI-115 for endometriosis has entered its final stage. Women's health is a key focus area for Hope Medicine, and we will drive this trial with the best speed and quality to bring this innovative treatment to patients as soon as possible."
About Endometriosis
Endometriosis is a common gynecological disease characterized by the implantation of endometrial cells outside the uterine cavity, typically presenting as a chronic inflammatory response. The endometrium is the mucosal tissue lining the uterine cavity, which undergoes hormone-dependent changes during the menstrual cycle. Endometriosis is common in women of reproductive age, with symptoms including lower abdominal and pelvic pain, dysmenorrhea, painful intercourse, and infertility. Comprehensive literature reports indicate that approximately 10% of women of reproductive age globally are affected by endometriosis, about 190 million women worldwide; 20%-50% of women with infertility have endometriosis, and 71%-87% of women with chronic pelvic pain have endometriosis. Endometriosis is one of the leading causes of dysmenorrhea, infertility, and chronic pelvic pain. The disease often leads to decreased quality of life, affecting patients' sexual health, psychological well-being, and social behavior. Globally, the disease represents a potential market size of approximately US$200 billion (according to McKinsey report), with significant unmet medical needs.
About Hope Medicine
Hope Medicine Inc. is a science-driven clinical-stage biopharmaceutical company with research laboratories and offices in Beijing, Shanghai, and Nanjing, China. HopeMed is established on the in-depth expertise in translational medicine and decades of research of Professor Rui-Ping Xiao's laboratory at the Institute of Molecular Medicine of Peking University. Based on excellent scientific research and to improve the quality of life, HopeMed is committed to the research, development, and commercialization of first-in-class medicines for common and major diseases that threaten human health.
Forward-Looking Statements
This press release contains forward-looking statements that are primarily based on the current outlook, expectations, estimates, and projections of the company's management team. When using "anticipate," "believe," "may," "design," "effect," "assess," "expect," "predict," "target," "aim," "purpose" and any other similar words and expressions, in references to the company, the intention of the statement is forward-looking. Forward-looking statements are not guarantee of future performance and subject to risks and uncertainties, many of which are difficult to predict and often beyond the company's control, which could cause actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; changes in applicable laws or regulations. The company undertakes no public announcement obligation to update or revise any forward-looking statement in this press release, or to publicly announce any such updates or revisions, to reflect changes in our expectations or any events, circumstances or assumptions that affect these statements.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis
